Invention Publication
- Patent Title: METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA
-
Application No.: US17878884Application Date: 2022-08-01
-
Publication No.: US20230158058A1Publication Date: 2023-05-25
- Inventor: Akin Akinc
- Applicant: Genzyme Corporation
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K31/7088
- IPC: A61K31/7088 ; A61P7/04
Abstract:
The invention relates to iRNA, e.g., double stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to treat a bleeding event in a subject having a hemophilia (e.g., with or without inhibitors).
Information query
